Nelson, C. E., Castellanos, R. M., Ann Ran, F., Yan, W., Zhang, F., Asokan, A., & Gersbach, C. A. (2015). 397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy. In Molecular Therapy (Vol. 23, pp. S157–S158). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)34006-0

Nelson, Christopher E., Ruth M. Castellanos, Fei Ann Ran, Winston Yan, Feng Zhang, Aravind Asokan, and Charles A. Gersbach. “397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy.” In Molecular Therapy, 23:S157–58. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)34006-0.

Nelson CE, Castellanos RM, Ann Ran F, Yan W, Zhang F, Asokan A, et al. 397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy. In: Molecular Therapy. Elsevier BV; 2015. p. S157–8.

Nelson, Christopher E., et al. “397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S157–58. Crossref, doi:10.1016/s1525-0016(16)34006-0.

Nelson CE, Castellanos RM, Ann Ran F, Yan W, Zhang F, Asokan A, Gersbach CA. 397. Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy. Molecular Therapy. Elsevier BV; 2015. p. S157–S158.